Alembic Pharma bags USFDA nod for Bromfenac Ophthalmic Solution Ruchika Sharma9 July 2024 2:47 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration...
Alembic Pharma receives 11 USFDA product approvals (final & tentative) during quarter ended 30 June Ruchika Sharma5 July 2024 4:16 PM ISTVadodara: Alembic Pharma has announced the receipt of 11 product approvals both final and tentative from the US Food & Drug...
Alembic Pharma gets tentative USFDA nod for cancer drug Ivosidenib Ruchika Sharma5 July 2024 11:15 AM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received tentative approval from the US Food & Drug...
Alembic Pharma bags USFDA tentative nod for Bosutinib Tablets to treat certain type of leukemia Ruchika Sharma1 July 2024 11:27 AM ISTBosutinib tablets are indicated for the treatment of a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia.
Alembic Pharma secures USFDA okay for Doxycycline Capsules for inflammatory lesions of rosacea Ruchika Sharma28 Jun 2024 5:41 PM ISTAlembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for...
USFDA nod to Alembic Pharma stroke and blood clots drug Dabigatran Etexilate Ruchika Sharma19 Jun 2024 12:12 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Alembic Pharma gets USFDA nod for Sacubitril and Valsartan Tablets for heart failure Ruchika Sharma30 May 2024 4:27 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration...
Alembic Pharma posts 17 pecent increase in Q4 profit Ruchika Sharma10 May 2024 12:47 PM ISTBengaluru: Alembic Pharma, an Indian generic drug manufacturer, has announced a 17 percent rise in fourth-quarter profit, propelled by strong...
USFDA approves Alembic Pharma five products in over a month Ruchika Sharma9 May 2024 1:05 PM ISTMumbai: Alembic Pharmaceuticals Limited announced today that it has received US Food & Drug Administration (USFDA) approvals on five of its...
Alembic Pharma gets USFDA EIR for Panelav Oncology formulation facility Ruchika Sharma6 May 2024 11:31 AM ISTVadodara: Alembic Pharma has announced that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug...
Alembic Pharma gets tentative USFDA nod for breast cancer drug Ribociclib in March Quarter Ruchika Sharma2 April 2024 3:17 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that the Company has received tentative approval for Ribociclib Tablets, 200 mg,...
